Tianeptine — an instance of drug-induced hepatotoxicity predicted by prospective experimental studies
- 1 January 1994
- journal article
- case report
- Published by Elsevier in Journal of Hepatology
- Vol. 21 (5) , 771-773
- https://doi.org/10.1016/s0168-8278(94)80237-8
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990
- Metabolic activation of the new tricyclic antidepressant tianeptine by human liver cytochrome P450Biochemical Pharmacology, 1990
- Tianeptine, a new tricyclic antidepressant metabolized by β-oxidation of its heptanoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in miceBiochemical Pharmacology, 1989
- Metabolic activation of the antidepressant tianeptineBiochemical Pharmacology, 1989
- Metabolic activation of the antidepressant tianeptineBiochemical Pharmacology, 1989
- 8 Acute and chronic drug-induced hepatitisBailliere's Clinical Gastroenterology, 1988
- Metabolic activation of the tricyclic antidepressant amineptine by human liver cytochrome P-450Biochemical Pharmacology, 1987
- Metabolic activation of the tricyclic antidepressant amineptine—IBiochemical Pharmacology, 1987
- Irreversible protein binding of [14C]imipramine with rat and human liver microsomesBiochemical Pharmacology, 1975